Skip to content

State Street Health Care Select Sector SPDR ETF

XLVNYSE ArcaA

$169.66−2.33 (−1.35%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 79 prints from 171.99 to 169.66. Range 169.55 to 172.32. Use the arrow keys to read each point.170.00170.50171.00171.5010 AM12 PM2 PM4 PM
Expense ratio
0.08%
Fund size
$44.3B
1Y total return
+23.0%
Yield · Last 12 months
1.48%
Holdings
64
Avg volume · 30D
9.4M sh
NAV per share
$170.81
52W range
low $141.05high $176.60
Launched
Filings
SEC EDGAR

The ETF.net XLV Grade

A

Score 84 out of 100

Rank
1 of 25
Six-pillar profile for XLV. Scores out of 100: Cost 98, Risk 73, Mission 84, Tradability 99, Holdings 39, Durability 87. Strongest: Tradability (99). Weakest: Holdings (39). Leans toward Tradability and Cost.

Score 84 of 100 falls in the A band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A98 out of 100
    Rank 1 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A84 out of 100
    Rank 1 of 11
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A73 out of 100
    Rank 6 of 24
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    A99 out of 100
    Rank 1 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    D39 out of 100
    Rank 20 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    A87 out of 100
    Rank 2 of 25

Our read on XLV

ETF.net Research

ALive since 1998, XLV is the original way to own health care: about 60 S&P 500 names, a 0.08% fee, and one of the busiest tickers in the sector. Big pharma and device makers, not small-cap biotech.

Stated mandate

The fund seeks to track, before expenses, the price and yield performance of the Health Care Select Sector Index, which represents the health care sector of the S&P 500 Index.

Why people hold it

  1. 010.08% a year against a cohort median of 0.50%. That ties it with FHLC as the cheapest in the group and edges VHT at 0.09%.
  2. 02One of the most actively traded funds in its category, which generally keeps bid-ask spreads thin whether you trade 10 shares or 10,000.
  3. 03Launched December 1998 as one of the first US sector funds, and it has tracked its S&P 500 health care index closely ever since.
  4. 04Covers the whole sector in one line: pharma, devices, providers, biotech, life-science tools and health tech. Pays quarterly.ssga.com

Worth knowing

  1. 01Cap-weighted and about 60 names deep, so the largest drug and device makers carry most of the weight.ssga.com
  2. 02S&P 500 members only. Mid- and small-cap health care names sit outside the mandate.
  3. 03One sector, one set of headlines: drug pricing rules, patent expirations and policy shifts move the whole basket together.

XLV Holdings

As of Oct 12, 2026
Asset class
Stocks
Holdings
64
Top-10 weight
60%
Largest holding
LLY15.2%

Sectors

  • Health Care99.3%
  • Technology0.7%

Geography

  • United States97.83%
  • Ireland2.17%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001LLYEli Lilly & Co15.20%5,693,961$6.6B583
002JNJJohnson & Johnson10.15%17,148,993$4.4B528
003ABBVAbbVie Inc7.87%12,574,953$3.4B522
004MRKMerck & Co. Inc.5.79%17,556,552$2.5B515
005UNHUnitedHealth Group Inc5.48%6,387,319$2.4B481
006TMOThermo Fisher Scientific Inc3.92%2,631,131$1.7B375
007AMGNAmgen Inc3.61%3,847,167$1.6B491
008GILDGilead Sciences Inc3.02%8,823,504$1.3B492
009ABTAbbott Laboratories2.78%12,313,537$1.2B376
010PFEPfizer Inc2.60%40,559,199$1.1B378
011ISRGIntuitive Surgical Inc2.41%2,513,913$1.1B410
012DHRDanaher Corp2.22%4,452,142$964M331
013VRTXVertex Pharmaceuticals Inc2.08%1,803,596$906M422
014BMYBristol Myers Squibb Co1.95%14,536,112$847M463
015MDTMedtronic PLC1.82%9,108,907$794M320

Showing 1–15 of 64 holdings

XLV Performance

Launched Dec 16, 1998

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

XLV$12,304
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. XLV $12,304. SPY $12,044. Use the arrow keys to read each point.$9,545$11,143$12,740Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for XLV. Periods over one year show the average yearly return.
PeriodXLV
Year to date+12.5%
1 month+4.4%
3 months+7.3%
1 year+23.0%
3 yearsper year+11.8%
5 yearsper year+8.3%
10 yearsper year+11.2%

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for XLV
YearReturn barXLV
2026 YTD+12.5%
2025+14.5%
2024+2.5%
2023+2.1%
2022−2.1%
2021+26.0%
2020+13.3%

XLV in the news

XLV Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
1.48%Last 12 months
Payout per share
$2.55Last 12 months
Last payment
$0.64 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 40 payments from 2017 to 2026 YTD. Mar 17, 2017 $0.27; Jun 16, 2017 $0.31; Sep 15, 2017 $0.30; Dec 15, 2017 $0.33; Mar 16, 2018 $0.30; Jun 15, 2018 $0.32; Sep 21, 2018 $0.37; Dec 21, 2018 $0.38; Mar 15, 2019 $0.34; Jun 21, 2019 $0.40; Sep 20, 2019 $0.38; Dec 20, 2019 $0.42; Dec 30, 2019 $0.67; Mar 23, 2020 $0.38; Jun 22, 2020 $0.42; Sep 21, 2020 $0.42; Dec 21, 2020 $0.46; Mar 22, 2021 $0.40; Jun 21, 2021 $0.48; Sep 20, 2021 $0.47; Dec 20, 2021 $0.53; Mar 21, 2022 $0.43; Jun 21, 2022 $0.50; Sep 19, 2022 $0.51; Dec 19, 2022 $0.56; Mar 20, 2023 $0.49; Jun 20, 2023 $0.54; Sep 18, 2023 $0.54; Dec 18, 2023 $0.60; Mar 18, 2024 $0.52; Jun 24, 2024 $0.57; Sep 23, 2024 $0.58; Dec 23, 2024 $0.62; Mar 24, 2025 $0.56; Jun 23, 2025 $0.63; Sep 22, 2025 $0.62; Dec 22, 2025 $0.66; Mar 23, 2026 $0.59; Jun 22, 2026 $0.66; Sep 21, 2026 $0.64. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 21, 2026Sep 23, 2026$0.64
Jun 22, 2026Jun 24, 2026$0.66
Mar 23, 2026Mar 25, 2026$0.59
Dec 22, 2025Dec 24, 2025$0.66
Sep 22, 2025Sep 24, 2025$0.62
Jun 23, 2025Jun 25, 2025$0.63
Mar 24, 2025Mar 26, 2025$0.56
Dec 23, 2024Dec 26, 2024$0.62
Sep 23, 2024Sep 25, 2024$0.58
Jun 24, 2024Jun 26, 2024$0.57
Mar 18, 2024Mar 21, 2024$0.52
Dec 18, 2023Dec 21, 2023$0.60

XLV Risk

How much the fund’s monthly returns vary, scaled to a year.
14.1%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.51
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−17.1%
Trough May 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.56
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

XLV Cost

Expense ratio0.08%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

No Health Care (Broad) fund charges less.

XLV costs $8.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.

Other funds in Health Care (Broad)